473249-01-3

Usage

Uses

Used in Pharmaceutical Industry:
1-(2-Fluorophenyl)propylamine is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of antidepressants and antipsychotics. Its structural properties allow for the creation of molecules with specific therapeutic effects on the central nervous system.
Used in Chemical Industry:
In the chemical industry, 1-(2-Fluorophenyl)propylamine is utilized as a precursor in the production of dyes and other organic compounds, where its fluorophenyl group imparts unique chemical and physical properties to the final products.
Used in Research and Development:
1-(2-Fluorophenyl)propylamine is employed as a research compound for exploring its potential in treating neurological disorders and other medical conditions, highlighting its importance in advancing scientific knowledge and drug discovery.

InChI:InChI=1/C9H12FN/c1-2-9(11)7-5-3-4-6-8(7)10/h3-6,9H,2,11H2,1H3

Relevant academic research and scientific papers

QUINOLINE 4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS NEUROKININ 3 (NK-3) RECEPTOR ANTAGONISTS

The invention relates to novel quinoline derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments particularly in treating disorders of the central nervous system (CNS).

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.